Abstract
The bidirectional interaction between undernutrition and infection can be devastating to child health. Nutritional deficiencies impair immunity and increase susceptibility to infection. Simultaneously, infections compound undernutrition by increasing metabolic demand, and impairing nutrient absorption. Treatment of acute malnutrition (wasting) can reverse some of its deleterious effects and reduce susceptibility to infectious diseases. Nutrition-specific approaches may be packaged with other interventions, including immunization, to support overall child health. To understand how mass nutritional supplementation, treatment of wasting, and vaccination affect the dynamics of a vaccine-preventable infection, we developed a population-level, compartmental model of measles transmission stratified by age and nutrition status. We simulated a range of scenarios to assess the potential reductions in measles infection and mortality associated with targeted therapeutic feeding for children who are wasted and with a mass supplementation intervention. Nutrition interventions were assumed to increase engagement with the health sector, leading to increased vaccination rates. We found that the combination of wasting treatment and mass supplementation coverage followed by an increase in vaccination coverage of non-wasted children from a baseline of 75% to 85%, leads to 34-57% and 65-77% reduction in measles infection and mortality and 56-60% reduction in overall mortality among wasted children, compared with the wasting treatment alone. Our work highlights the synergistic benefits that may be achieved by leveraging mass nutritional supplementation as a touch point with the health system, to increase rates of vaccination and improve child survival beyond what would be expected from the additive benefits of each intervention.
Competing Interest Statement
Kevin P.Q. Phelan, The Alliance for International Medical Action (ALIMA) serves on the Social Purposes Advisory Commission of Nutriset, a main producer of lipid-based nutrient supplement products. Other authors declare no conflict of interest.
Funding Statement
The funders had no role in study design, data collection, data analysis, the decision to publish, or preparation of the manuscript. The content of this article is solely the responsibility of the authors and does not necessarily represent the official views of their respective employers or funders.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Non applicable
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
↵§ Kevin P.Q. Phelan and Indi Trehan are joint senior authors.
Other information: Supplementary Information
skripla{at}ul.edu.lr
assaf{at}uw.edu
kevin.mccarthy{at}gatesfoundation.org
josh.proctor{at}gatesfoundation.org
guillaume.chabot-couture{at}gatesfoundation.org
bma85{at}uw.edu
kevin.phelan{at}alima.ngo
itrehan{at}uw.edu
Data Availability
There are no data underlying this work.
